LifeStance Health Group (NASDAQ:LFST) Stock Price Expected to Rise, KeyCorp Analyst Says

LifeStance Health Group (NASDAQ:LFST) had its target price hoisted by equities research analysts at KeyCorp from $13.00 to $15.00 in a report released on Monday, Benzinga reports. The firm presently has an “overweight” rating on the stock. KeyCorp’s target price suggests a potential upside of 23.76% from the company’s previous close.

LFST has been the subject of several other research reports. Zacks Research lowered shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 13th. Canaccord Genuity Group lifted their price objective on shares of LifeStance Health Group from $13.00 to $15.00 and gave the company a “buy” rating in a research report on Wednesday, September 9th. JPMorgan Chase & Co. boosted their target price on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company a “neutral” rating in a research note on Friday, August 14th. Wall Street Zen cut shares of LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 5th. Finally, Barclays raised their price target on shares of LifeStance Health Group from $13.00 to $15.00 and gave the company an “overweight” rating in a research note on Thursday, September 10th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $13.12.

LifeStance Health Group Stock Performance

Shares of LFST stock opened at $12.12 on Monday. The company has a market cap of $4.63 billion, a P/E ratio of 93.24 and a beta of 1.24. The business has a 50 day moving average of $12.12 and a two-hundred day moving average of $9.66. LifeStance Health Group has a 52 week low of $4.77 and a 52 week high of $13.56. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The business had revenue of $435.35 million for the quarter, compared to the consensus estimate of $414.58 million. During the same quarter last year, the business posted ($0.01) EPS. The business’s revenue was up 26.1% on a year-over-year basis. As a group, analysts anticipate that LifeStance Health Group will post 0.16 EPS for the current year.

Insider Buying and Selling

In related news, COO Lisa Miller sold 47,912 shares of the stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $10.85, for a total value of $519,845.20. Following the completion of the transaction, the chief operating officer owned 281,289 shares in the company, valued at $3,051,985.65. This represents a 14.55% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CTO Vukasin Paunovich sold 42,067 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $12.87, for a total transaction of $541,402.29. Following the transaction, the chief technology officer directly owned 205,379 shares in the company, valued at approximately $2,643,227.73. The trade was a 17.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 13,777,580 shares of company stock valued at $146,433,781 over the last 90 days. 3.50% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On LifeStance Health Group

Institutional investors have recently added to or reduced their stakes in the company. Assetmark Inc. grew its stake in shares of LifeStance Health Group by 17.0% in the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock worth $60,000 after purchasing an additional 1,367 shares during the last quarter. Allworth Financial LP boosted its holdings in LifeStance Health Group by 7.7% during the second quarter. Allworth Financial LP now owns 26,532 shares of the company’s stock worth $284,000 after buying an additional 1,889 shares in the last quarter. Diversified Trust Co grew its position in LifeStance Health Group by 14.8% in the first quarter. Diversified Trust Co now owns 21,532 shares of the company’s stock worth $137,000 after buying an additional 2,770 shares during the last quarter. IFP Advisors Inc increased its holdings in shares of LifeStance Health Group by 316.5% in the second quarter. IFP Advisors Inc now owns 3,694 shares of the company’s stock valued at $40,000 after buying an additional 2,807 shares in the last quarter. Finally, KBC Group NV bought a new position in shares of LifeStance Health Group in the first quarter valued at $29,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc is a U.S.-based healthcare company that provides outpatient mental health services through a network of clinicians. Its services are delivered through both in-person appointments and a virtual care platform, allowing patients to access care in a range of settings.

The company offers psychiatric evaluation and treatment, psychotherapy, medication management, psychological and neuropsychological testing, and related behavioral health services. LifeStance serves children, adolescents, and adults, addressing conditions such as anxiety, depression, attention-deficit/hyperactivity disorder, and other mental health and behavioral concerns.

LifeStance operates across multiple states in the United States and combines company-operated clinics with telehealth services.